Correlation Between Telix Pharmaceuticals and Star Combo

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Star Combo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Star Combo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Star Combo Pharma, you can compare the effects of market volatilities on Telix Pharmaceuticals and Star Combo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Star Combo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Star Combo.

Diversification Opportunities for Telix Pharmaceuticals and Star Combo

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Telix and Star is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Star Combo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Combo Pharma and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Star Combo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Combo Pharma has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Star Combo go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Star Combo

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to under-perform the Star Combo. But the stock apears to be less risky and, when comparing its historical volatility, Telix Pharmaceuticals is 3.14 times less risky than Star Combo. The stock trades about -0.09 of its potential returns per unit of risk. The Star Combo Pharma is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  14.00  in Star Combo Pharma on October 6, 2024 and sell it today you would earn a total of  1.00  from holding Star Combo Pharma or generate 7.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Star Combo Pharma

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Star Combo Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Star Combo Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Star Combo unveiled solid returns over the last few months and may actually be approaching a breakup point.

Telix Pharmaceuticals and Star Combo Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Star Combo

The main advantage of trading using opposite Telix Pharmaceuticals and Star Combo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Star Combo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Combo will offset losses from the drop in Star Combo's long position.
The idea behind Telix Pharmaceuticals and Star Combo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation